Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era-Reference-Cited by-同舟云学术

Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era

Published:2022-01 Issue:1 Volume:24 Page:49-58
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Ishii Akira,Jo Tomoyasu^ORCID,Arai Yasuyuki^ORCID,Oshima Shinichiro,Kanda Junya,Kitawaki Toshio^ORCID,Matsui Keiko,Niwa Norimi,Nakagawa Yoko,Takaori-Kondo Akifumi,Nagao Miki

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference49 articles.

1. Hematopoietic stem-cell transplantation;Copelan;N Engl J Med,2006

2. Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations;Giralt;Biol Blood Marrow Transplant,2014

3. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation;Pusic;Biol Blood Marrow Transplant,2008

4. Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma;Gertz;Bone Marrow Transplant,2009

5. Novel strategies for blood stem cell mobilization: special focus on plerixafor;Jantunen;Expert Opin Biol Ther,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors for peripheral blood stem cell mobilization in multiple myeloma in the era of novel therapies: A single‐center experience;Cancer Medicine;2024-06

2. Analysis of Factors Affecting Hematopoietic Stem Cell Mobilization Efficiency and Early Hematopoietic Reconstruction Indicators during Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation;Global Medical Genetics;2024-04-18

3. Predicting the CD34 content of mobilized peripheral blood leukapheresis products: single institution experience over 20 years;Cytotherapy;2024-02

4. Benefits of plerixafor for mobilization of peripheral blood stem cells prior to autologous transplantation: a dual-center retrospective cohort study;Cytotherapy;2023-07

5. Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor;Journal of Clinical Medicine;2023-01-12